Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple diet cut hospital stays after lung surgery by 30%?

NCT ID NCT07159659

Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a medium-chain triglyceride (MCT) diet, given after lung resection surgery, can help people leave the hospital sooner. The diet bypasses the lymphatic system, potentially reducing fluid buildup and complications. Researchers will compare hospital stay length and recovery in 210 adults undergoing lung surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
medium-chain triglyceride (MCT) diet
What this could lead to
If it works, this diet could shorten hospital stays and speed recovery after lung surgery, reducing healthcare costs and patient discomfort.
What could go wrong
This is a small, early-stage trial with only 210 participants. The diet may not significantly reduce hospital stay, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 210 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: General Inclusion Criteria for All procedures: 1. Age between 18 - 80 years 2. Body mass index \<35 kg/m2 3. Suitable for minimally invasive surgery 4. Willingness to participate as demonstrated by giving informed consent Project-specific Criteria: 1\. Patients performed lobectomy with lymph node dissection Exclusion Criteria: Patient general exclusion criteria: 1. Contraindication to general anesthesia 2. Severe concomitant illness that drastically shortens life expectancy or increases the risk of therapeutic intervention 3. Untreated active infection 4. Non-correctable coagulopathy 5. Emergency surgery 6. Vulnerable population (e.g. mentally disabled, pregnancy) Project-specific Criteria 1. Segmentectomy 2. Pleurodesis 3. Esophageal procedures 4. Redo/readmitted patients for lung resection 5. Chylothorax (Triglyceride \> 110 mL, excluded at day 1 routine lab check) 6. Air leak (\> 30 mL/min when back to ward) 7. Heart Failure 8. Renal failure (estimated GFR \< 30; CKD grading stage 4-5) 9. Moderate to severe adhesion (defined at randomization by surgeon; criteria include estimated surface area of adhesion and staging) 10. History of tuberculosis or empyema

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Thoracic neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neoplasm of thorax Thoracic Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Thoracic neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Prince of Wales Hospital

    RECRUITING

    Shatin, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.